IP Library › Granted Patent US 12,439,950
Granted Patent B2
US 12,439,950 · App. 18/582,900 · Granted Oct 14, 2025

Methods and systems for incorporating nicotine into oral products

Inventors: Feng Gao (Midlothian, VA); Shuzhong Zhuang (Glen Allen, VA); Diane Gee (Chesterfield, VA)
Assignee: Altria Client Services LLC
A24B15/16A23G4/06A24B13/00A24B15/285A24B15/303C07D401/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,439,950
App. No.
18/582,900
Granted
Oct 14, 2025
Kind
B2
Abstract

This document provides methods and systems for stabilizing nicotine and incorporating nicotine into one or more oral products. This document also provides oral products. Nicotine can be stabilized by mixing liquid nicotine with cellulosic fiber such that the liquid nicotine absorbs into pores of the cellulosic fiber to form a cellulosic fiber-nicotine mixture. In some cases, a cellulosic fiber-nicotine mixture can be combined with one or more binders and molded into an oral product.

Claims (41)

1. An oral product comprising:

a porous pouch; and

a composition within the porous pouch, the composition including,

a mixture including,

microcrystalline cellulose, and

diluted nicotine, the diluted nicotine including,

a triglyceride, and

liquid nicotine.

2. The oral product of claim 1 , wherein the triglyceride includes medium chain triglycerides.

3. The oral product of claim 1 , wherein the liquid nicotine is tobacco-derived nicotine.

4. The oral product of claim 1 , wherein the liquid nicotine is synthetic nicotine.

5. The oral product of claim 1 , wherein the composition includes the liquid nicotine in an amount greater than or equal to 1 mg.

6. The oral product of claim 1 , wherein the composition further includes a sweetener.

7. The oral product of claim 6 , wherein the sweetener includes a sugar alcohol.

8. The oral product of claim 7 , wherein the sugar alcohol includes xylitol.

9. The oral product of claim 6 , wherein the sweetener includes sucralose.

10. The oral product of claim 1 , wherein the composition further includes an antioxidant.

11. The oral product of claim 1 , wherein the composition further includes a flavorant.

12. The oral product of claim 1 , wherein the diluted nicotine is absorbed in the microcrystalline cellulose.

13. An oral product comprising:

a porous pouch; and

a composition within the porous pouch, the composition including,

microcrystalline cellulose,

diluted nicotine absorbed in the microcrystalline cellulose, the diluted nicotine including,

a medium chain triglyceride, and

nicotine,

a sweetener,

a flavorant,

an antioxidant.

14. The oral product of claim 13 , wherein the sweetener includes a sugar alcohol.

15. The oral product of claim 14 , wherein the sweetener further includes sucralose.

16. The oral product of claim 15 , wherein the sugar alcohol includes xylitol.

17. The oral product of claim 13 , wherein the nicotine includes tobacco-derived nicotine.

18. The oral product of claim 13 , wherein the nicotine includes synthetic nicotine.

19. The oral product of claim 13 , wherein the composition includes the nicotine in an amount greater than or equal to 1 mg.

20. An oral product comprising:

a porous pouch; and

a composition within the porous pouch, the composition including, microcrystalline cellulose, and

diluted nicotine absorbed in pores of the microcrystalline cellulose, the diluted nicotine including,

a medium chain triglyceride, and

liquid nicotine.

Continuity (6)
Continuation 17380255 · Jul 20, 2021
Continuation 16507243 · Jul 10, 2019
Division 15351571 · Nov 15, 2016
Continuation 14333877 · Jul 17, 2014
Provisional Application 61856409 · Jul 19, 2013
Related Publication 20240188621A1 · Jun 13, 2024
References Cited (69)
US 2162738A · McCoy · 1939 [cited by applicant]
US 3139436A · Bicking · 1964 [cited by applicant]
US 3396735A · Von Bethmann et al. · 1968 [cited by applicant]
US 4153063A · Roselius et al. · 1979 [cited by applicant]
US 4448208A · Friedrich et al. · 1984 [cited by applicant]
US 4528993A · Sensabaugh, Jr. et al. · 1985 [cited by applicant]
US 4660577A · Sensabaugh et al. · 1987 [cited by applicant]
US 4848373A · Lenkey · 1989 [cited by applicant]
US 5372149A · Roth et al. · 1994 [cited by applicant]
US 5487792A · King et al. · 1996 [cited by applicant]
US 5939100A · Albrechtsen et al. · 1999 [cited by applicant]
US 20020059939A1 · Fox · 2002 [cited by applicant]
US 20040010787A1 · Traut et al. · 2004 [cited by applicant]
US 20040107971A1 · De · 2004 [cited by applicant]
US 20040118422A1 · Lundin et al. · 2004 [cited by applicant]
US 20050053665A1 · Ek et al. · 2005 [cited by applicant]
US 20050178398A1 · Breslin et al. · 2005 [cited by applicant]
US 20070269386A1 · Steen et al. · 2007 [cited by applicant]
US 20090293895A1 · Axelsson et al. · 2009 [cited by applicant]
US 20100004294A1 · Axelsson et al. · 2010 [cited by applicant]
US 20110200670A1 · Thakkar · 2011 [cited by applicant]
US 20120100194A1 · Yamai et al. · 2012 [cited by applicant]
US 20120128734A1 · Hubinette · 2012 [cited by examiner]
US 20130209540A1 · Duggins · 2013 [cited by examiner]
US 20140000634A1 · Mishra et al. · 2014 [cited by applicant]
CN 102754907A · 2012 [cited by applicant]
CN 103040090A · 2013 [cited by applicant]
JP H9504305A · 1997 [cited by applicant]
JP 2002173413A · 2002 [cited by applicant]
JP 2004527453A · 2004 [cited by applicant]
JP 2007505037A · 2007 [cited by applicant]
JP 2008531008A · 2008 [cited by applicant]
JP 2009545315A · 2009 [cited by applicant]
JP 2011132156A · 2011 [cited by applicant]
JP 2015503930A · 2015 [cited by applicant]
JP 2015506979A · 2015 [cited by applicant]
WO WO2004056363A2 · 2004 [cited by applicant]
WO WO2004064811A1 · 2004 [cited by applicant]
WO 2007037962A1 · 2007 [cited by applicant]
WO WO2007104574A2 · 2007 [cited by applicant]
WO WO2007104573A2 · 2007 [cited by applicant]
WO WO2009037319A2 · 2009 [cited by applicant]
WO WO2011127182A1 · 2011 [cited by applicant]
Jadhav et al, Triglycerides of medium chain fatty acids: a concise review, J Food Sci Tech, (2023) 60(8):2143-2152, [online], retrieved Jan. 25, 2025, [retrieved from Internet],<URL: https://doi.org/10.1007/s13197-022-0… [cited by examiner]
European Communication pursuant to Article 94(3) EPC for EP Application 19194904.9 dated Aug. 1, 2024 (5 pages). [cited by applicant]
(−) Nicotine, product information sheet, Sigma-Aldrich, [online], retrieved from the Internet, [retrieved Jan. 19, 2016,<URL: http://www.sigmaaldrich.com/catalog/product/sigma/n3876?lang=en&region=US. [cited by applicant]
Ethyl Acohol, Pure, product information sheet, Sigma-Aldrich, [online], retrieved from the Internet, [retrieved Jan. 19, 2016,<URL: http:///www.sigmaaldrich.com/catalog/product/sia1/459844?lang=en&region=US>. [cited by applicant]
Hagiopol et al. Chemistry of Modern Papermaking, CRC Press, p. 52 (2011). [cited by applicant]
International Preliminary Report on Patentability in International Application No. PCT/US2014/046999, issued on Jan. 19, 2016, 7 pages. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2014/046999, mailed on Oct. 27, 2014, 14 pages. [cited by applicant]
Lovikka et al. “Porosity wood pulp fibers in wet and highly open dry state,” Micropor & Mesopor Mtls 234, pp. 326-335, [online], <URL: http://ac.els-cdn.com/S1387181116302931/1-s2.0-S13871811163029131-main.pdf?_tid=635f… [cited by applicant]
Japanese Decision of Rejection for Japanese Application No. 2016-527096 dated Dec. 17, 2018, English translation thereof. [cited by applicant]
European Search Report for Application No. 19194904.9-1105, dated Feb. 3, 2020. [cited by applicant]
Japanese Notice of Reasons for Rejection for corresponding Application No. 2016-527096, dated May 11, 2020. [cited by applicant]
European Notice of Opposition for Application No. 14747264.1, dated Jun. 12, 2020. [cited by applicant]
Avicel PH Binders, FMC BioPolymer, pp. 2-13, retrieved from www.fmcbiopolymer.com, 2005. [cited by applicant]
Japanese Reasons for Rejection for corresponding Application No. 2019-077104, dated Jul. 29, 2020. [cited by applicant]
Canadian Office Action for corresponding Application No. 2,918,271 dated Oct. 7, 2020 (4 pages). [cited by applicant]
European Communication pursuant to Rule 114(2) EPC dated Feb. 2, 2021 for corresponding European Application No. 19194904.9. [cited by applicant]
European Communication pursuant to Rule 114(2) EPC dated Jan. 21, 2021 for corresponding European Application No. 14747264.1. [cited by applicant]
European Communication dated Feb. 22, 2021 in corresponding European Application No. 14747264.1 (12 pages). [cited by applicant]
European Communication regarding Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC dated Mar. 31, 2021 in European Application No. 14747264.1 (10 pages). [cited by applicant]
Canadian Office Action dated Mar. 31, 2021 in corresponding Canadian Application 2918271 (3 pages). [cited by applicant]
European Office Action for corresponding EP Application 19194904.9 dated Oct. 22, 2021 (5 pages). [cited by applicant]
Japanese Office Action for corresponding JP Patent Application No. 2021-018694 dated May 18, 2022, with English language translation (8 pages). [cited by applicant]
Japanese Office Action for corresponding JP Application 2022-158223 dated Aug. 23, 2023, with English language translation (6 pages). [cited by applicant]
European Notification for EP Application No. 14747264.1 dated Jan. 2, 2024 including Letter of the Opponent dated Dec. 20, 2023 (6 pages). [cited by applicant]
Japanese Decision to Grant a Patent for corresponding JP Application 2024-014188 dated Feb. 25, 2025. [cited by applicant]
European Communication pursuant to Article 94(3) EPC for EP Application 19194904.9 dated Jun. 23, 2025. [cited by applicant]